We have developed an immunotherapeutic Tumor Agnostic Cancer Vaccine (TACV) for treating dogs with cancer. Our methodology has several advantages. The cancer can be treated immediately since many canine cancers can be diagnosed by a general practice veterinarian by histopathic evaluation. Dosing is by the size of the cancer not the cancer type. The microtumor environment of the tumor creates the antigens needed to kill the cancer.
